Clinical trial
Evaluating Oral Peri-operative Acetylsalicylic Acid in Subjects Undergoing Endovascular Coiling-only of Unruptured Brain Aneurysms(EVOLVE): A Phase 3 Multicenter Randomized Study
NCT04192955 is registered in ClinicalTrials.gov with University of Calgary as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluating Oral Peri-operative Acetylsalicylic Acid in Subjects Undergoing Endovascular Coiling-only of Unruptured Brain Aneurysms(EVOLVE): A Phase 3 Multicenter Randomized Study
- Lead sponsor
- University of Calgary
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- July 14, 2020
- Completion date
- July 31, 2027
- Enrollment
- 440 (estimated)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.
unruptured cerebral aneurysm